UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
BIO-RESPONSE, INC. (now known as Liberty Group Holdings Corporation)
(Name of Issuer)
Common Stock
(Title of Class of Securities)
530550 10 2
(CUSIP Number)
Mr. Barry L. Hawk David Lubin, Esq.
c/o Liberty Group Holdings, Inc. Herrick, Feinstein LLP
11 52nd Street 2 Park Avenue
Brooklyn, New York 11232 New York, New York 10016
(718) 492-0793 (212) 592-1400
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 23, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d- 1(b)(3) or (4), check the following box .
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 4 Pages
<PAGE>
CUSIP No. 530550 10 2 13D Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Steel II Trust (the "Trust")
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 498,250
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
None
OWNED BY
-----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 498,250
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
None
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
498,250 shares of Issuer Common Stock
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[-]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.82
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
00
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 530550 10 2 13D Page 3 of 4 Pages
- --------------------------------------------------------------------------------
Item 1. Security and Issuer.
Common Stock, par value $.004 per share
Bio-Response, Inc. (now known as Liberty Group Holdings, Inc.)
11 52nd Street
Brooklyn, New York 11232
- --------------------------------------------------------------------------------
Item 2. Identity and Background.
(a) Steel II Trust
(b) 638 Willow Road
West Hempstead, NY 11552
(c) N/A
(d) N/A
(e) N/A
(f) N/A
- --------------------------------------------------------------------------------
Item 3. Source and Amount of Funds or Other Consideration.
N/A
- --------------------------------------------------------------------------------
Item 4. Purpose of Transaction.
As of November 23, 1999, the issuer consummated a merger with Liberty
Group Holdings Corporation, a Delaware corporation ("Liberty"),
pursuant to the Agreement and Plan of Merger (the "Merger Agreement")
by and among the Issuer, Liberty and BR Acquisition Corp., a Delaware
corporation, a wholly owned subsidiary of the Issuer.
Under the terms of the Merger Agreement, the Issuer exchanged shares
of Common stock for all of the outstanding shares of Liberty capital
stock.
(a) - (j) The undersigned has no plans or proposals which would result
in any of the actions enumerated in Item 4(a) through (j) of Schedule
13D.
- --------------------------------------------------------------------------------
Item 5. Interest in Securities of the Issuer.
(g) The Trust is the owner of 498,250 shares of Issuer Common Stock, which
shares represent 7.82% of the total outstanding shares of Issuer
Common Stock as of November 23, 1999. The total number of outstanding
shares includes those shares issued in connection with the Merger.
(h) Lisa Hawk and David Lubin, the Trustees of the Trust, have the sole
power to vote or direct the vote of the Shares.
- --------------------------------------------------------------------------------
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None
- --------------------------------------------------------------------------------
Item 7. Material to be Filed as Exhibits.
Asset Purchase Agreement*
Escrow Agreement*
Voting Trust Agreement*
- -------------------------------
*Included as Exhibit to the Company's Current Report on Form 8-K, filed
November 26, 1999.
- --------------------------------------------------------------------------------
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
November 23, 1999
--------------------- ------------------------
Date David Lubin, Trustee*
- -------------------------------
*The Trustee executes this Schedule 13D solely in his fiduciary capacity as
trustee of the Trust named herein, and recourse against the Trust shall be
limited solely to the assets of the Trust and no recourse shall be had
against the trustee thereof.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
